Populations of diamondback moth, Plutella xylostella (L.), sampled from commercial fields of crucifers in three states of Mexico, were tested for susceptibility to commercial formulations of Bacillus thuringiensis subsp. kurstaki (Berliner) (Dipel 2X), B. thuringiensis subsp. aizawai (XenTari), delta endotoxin Cry 1C (MC), and CryIA(c) (MVP), and a mixture of B. thuringiensis subsp. kurstaki and subsp. aizawai (Agree). Leaf-dip bioassays confirmed variation in susceptibility of up to 13-fold for MVP, 12-fold for Dipel 2X, sevenfold for XenTari, fivefold for Agree, and less than fivefold for MC. Comparisons with previously published data indicate that at least the 12-fold variation in Dipel 2X would result in significant differences in control in the field. Based on the LC99 values observed for the products, we propose discriminating concentrations for each product. To ensure continued performance in the field we suggest that a resistance monitoring program be implemented to detect any changes in susceptibility to B. thuringiensis products and specific toxins and that their use be restricted to one generation per crop and that they be rotated with other groups of insecticides. Furthermore, we suggest enforcement of a crucifer host-free period and the development and implementation of cultural and biological control strategies to reduce overall population pressure so that fewer insecticidal treatments will be needed.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 93 • No. 3